切换至 "中华医学电子期刊资源库"
高级检索
中华普通外科学文献(电子版)

中华普通外科学文献(电子版) ›› 2015, Vol. 09 ›› Issue (04) : 286 -290. doi: 10.3877/cma.j.issn.1674-0793.2015.04.007

所属专题： 文献；

论著

不解剖肝门的半肝与全肝入肝血流阻断在肝细胞癌患者行肝切除术中的临床应用比较
林建宇1, 陈永标1, 吕立志1, 江艺1,†()   
  1. 1. 350025　福州，解放军南京军区福州总医院肝胆外科
  • 收稿日期:2015-02-28 出版日期:2015-08-01
  • 通信作者: 江艺
  • 基金资助:
    福建省科技重点项目(2014Y0034)

Comparison of half and total vascular inflow occlusion without hilus dissection in hepatocellular carcinoma patients undergoing hepatectomy

Jianyu Lin1, Yongbiao Chen1, Lizhi Lyu1, Yi Jiang1,†()   

  1. 1. Department of Hepatobiliary Surgery, Fuzhou General Hospital of Nanjing Military Area Command of Chinese PLA, Fuzhou 350025, China
  • Received:2015-02-28 Published:2015-08-01
  • Corresponding author: Yi Jiang
  • About author:
    Corresponding author: Jiang Yi, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

林建宇, 陈永标, 吕立志, 江艺. 不解剖肝门的半肝与全肝入肝血流阻断在肝细胞癌患者行肝切除术中的临床应用比较[J/OL]. 中华普通外科学文献(电子版), 2015, 09(04): 286-290.

Jianyu Lin, Yongbiao Chen, Lizhi Lyu, Yi Jiang. Comparison of half and total vascular inflow occlusion without hilus dissection in hepatocellular carcinoma patients undergoing hepatectomy[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2015, 09(04): 286-290.

目的

探讨不解剖肝门的半肝入肝血流阻断(HIO)与全肝入肝血流阻断(TIO)在肝细胞癌患者行肝切除术中的临床应用效果。

方法

回顾性分析肝细胞癌行肝切除术患者63例,并随机分为两组,HIO组(33例)行不解剖肝门的半肝入肝血流阻断联合控制性低中心静脉压肝切除,TIO组(30例)行全肝入肝血流阻断联合控制性低中心静脉压肝切除。比较两组手术时间、血流阻断时间、术中出血量、术中输血情况,以及术后住院时间、ICU时间、术后第1、3天肝功能。

结果

两组手术时间、血流阻断时间、术后ICU时间、术中出血量、术中输血情况差异无统计学意义, HIO组术后住院时间显著短于TIO组[(14.1±5.5) d vs (17.2±5.8)d,t=-2.142,P=0.036];术后第1天HIO组患者血清白蛋白(Alb)水平显著高于TIO组[(34.2±3.5)g/L vs (31.6±3.8)g/L,t=2.784,P=0.007],其余肝功指标(ALT、AST、AKP、GGT、TB、DB)在术后第1天的水平差异无统计学意义,术后第3天两组间肝功指标水平差异无统计学意义。

结论

两种肝血流阻断技术同样安全、有效,半肝入肝血流阻断在术后住院时间及早期Alb水平恢复上更优。

关键词: 肝细胞癌, 肝切除术, 半肝入肝血流阻断, 全肝入肝血流阻断
Objective

To compare the efficacy of half versus total vascular inflow occlusion without hilus dissection in hepatocellular carcinoma (HCC) patients undergoing hepatectomy.

Methods

Sixty-three HCC patients undergoing hepatectomy were divided into two groups: half vascular inflow occlusion group (HIO) and total vascular inflow occlusion group (TIO). There were no hilus dissection and combined controlled low central venous pressure in both groups. Operation time, occlusion time, postoperative hospital stay, postoperative ICU stay, blood loss and transfusion during operation and postoperative day 1 and day 3 liver functions were compared.

Results

Operation time, occlusion time, postoperative ICU stay, blood loss and transfusion during operation had no significant differences between two groups. Postoperative hospital stay was significantly shorter in HIO group [(14.1±5.5) d vs (17.2±5.8) d, t=-2.142, P=0.036]. Postoperative day 1 serum albumin level was significantly higher in HIO group [(34.2±3.5) g/L vs (31.6±3.8) g/L, t=2.784, P=0.007], while levels of ALT, AST, AKP, GGT, TB, DB had no significant differences between two groups. Postoperative day 3 liver functions had no significant differences between two groups.

Conclusion

Both occlusion methods are safe and effective, while half vascular inflow occlusion leads to shorter postoperative hospital stay and higher serum albumin level the first day after operation.

Key words: Hepatocellular carcinoma, Hepatectomy, Half vascular inflow occlusion, Total vascular inflow occlusion
表1 两组患者基本资料比较
项目 HIO组 TIO组 统计值 P值
例数 33 30 ? ?
年龄(岁,±s) 49.9±10.9 53.2±10.2 -1.234 0.222
性别(例) ? ? 2.438 0.118
? 男 25 28 ? ?
? 女 8 2 ? ?
术前Child-Pugh分级(例) ? ? 0.000 1.000
? A 32 29 ? ?
? B 1 1 ? ?
肿瘤部位(例) ? ? 0.164 0.686
? 肝右叶 25 24 ? ?
? 肝左叶 8 6 ? ?
肿瘤数目(例) ? ? 0.379 0.538
? 单发 32 27 ? ?
? 多发 1 3 ? ?
是否有大血管侵犯(例) ? ? 0.000 1.000
? 是 2 2 ? ?
? 否 31 28 ? ?
肿瘤直径(cm,±s) 5.5±4.3 6.4±4.2 -0.183 0.419
ALT(U/L,±s) 40.7±33.9 35.1±15.7 0.791 0.432
AST(U/L,±s) 45.0±24.3 52.2±31.0 -1.031 0.307
AKP(U/L,±s) 87.5±36.7 105.6±72.1 -1.271 0.208
GGT(U/L,±s) 70.1±63.1 113.8±167.8 -1.342 0.188
TB(μmol/L,±s) 15.4±6.5 13.5±6.6 1.182 0.242
DB(μmol/L,±s) 4.5±2.4 4.0±1.7 0.767 0.134
Alb(g/L,±s) 40.9±4.5 39.2±3.5 1.708 0.093
手术方式(例) ? ? 1.310 0.519
? 局部切除 23 21 ? ?
? 肝段切除 8 5 ? ?
? 半肝切除 2 4 ? ?
表2 两组手术时间、血流阻断时间、术后住院时间、术后ICU时间(±s, t检验)
组别 手术时间(min) 血流阻断时间(min) 术后住院时间(d) 术后ICU时间(d)
HIO组 140.7±37.4 21.4±8.0 14.1±5.5 2.4±1.6
TIO组 145.5±74.0 19.0±8.7 17.2±5.8 2.8±1.4
t值 -0.327 1.108 -2.142 -1.047
P值 0.745 0.272 0.036 0.299
表3 两组术后第1天肝功能指标比较(±s, t检验)
组别 ALT(U/L) AST(U/L) AKP(U/L) GGT(U/L) TB(μmol/L) DB(μmol/L) Alb(g/L)
HIO组 486.6±359.6 565.9±435.7 99.7±42.5 60.6±54.2 23.5±12.7 6.6±5.2 34.2±3.5
TIO组 477.3±299.5 569.7±318.6 98.1±41.0 66.1±56.4 20.2±8.1 6.3±3.0 31.6±3.8
t值 0.112 -0.039 0.155 -0.396 1.183 0.333 2.784
P值 0.911 0.969 0.878 0.693 0.241 0.740 0.007a
表4 两组术后第3天肝功能指标比较(±s, t检验)
组别 ALT(U/L) AST(U/L) AKP(U/L) GGT(U/L) TB(μmol/L) DB(μmol/L) Alb(g/L)
HIO组 228.3±128.2 100.7±23.3 101.5±18.7 68.0±38.1 19.0±6.7 5.8±3.1 28.1±2.9
TIO组 233.2±101.0 102.5±34.2 102.9±22.1 65.0±25.4 18.6±4.5 5.9±2.1 28.5±2.8
t值 -0.166 -0.251 -0.269 0.368 0.235 -0.117 -0.605
P值 0.869 0.803 0.789 0.714 0.815 0.907 0.547
[1]
Nagorney DM, van Heerden JA, Ilstrup DM, et al. Primary hepatic malignancy: surgical management and determinants of survival[J]. Surgery, 1989, 106(4): 740-749.
[2]
Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade[J]. Ann Surg, 2002, 236(4): 397-407.
[3]
Kokudo N, Vera DR, Tada K, et al. Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis[J]. World J Surg, 2002, 26(11): 1342-1347.
[4]
de Boer MT, Molenaar IQ, Porte RJ. Impact of blood loss on outcome after liver resection[J]. Dig Surg, 2007, 24(4): 259-264.
[5]
Elijah Dixon, Charles M. Vollmer Jr, et al. Vascular occlusion to decrease blood loss during hepatic resection[J]. Am J Surg, 2005, 190(1): 75-86.
[6]
van Gulik TM, de Graaf W, Dinant S, et al. Vascular occlusion techniques during liver resection[J]. Dig Surg, 2007, 24(4): 274-281.
[7]
Cherqui D, Alon R, Lauzet JY, et al. Limitation of blood transfusions during hepatectomies. Study of 150 consecutive hepatic resections on healthy and pathological livers[J]. Gastroenterol Clin Biol, 1996, 20(2): 132-138.
[8]
Miyagawa S, Makuuchi M, Kawasaki S, et al. Criteria for safe hepatic resection[J]. Am J Surg, 1995, 169(6): 589-594.
[9]
Dünschede F1, Erbes K, Kircher A, et al. Reduction of ischemia reperfusion injury after liver resection and hepatic inflow occlusion by α-Iipoic acid in humans[J]. World J Gastroenterol, 2006,12(42): 6812-6817.
[10]
Carson JL, Hill S, Carless P, et al. Transfusion triggers: a systematic review of the literature[J]. Transfus Med Rev, 2002, 16(3): 187-199.
[11]
Agarwal N, Murphy JG, Cayten CG, et al. Blood transfusion increases the risk of infection after trauma[J]. Arch Surg, 1993, 128(2): 171-177.
[12]
Yamamoto J, Kosuge T, Takayama T, et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy[J]. Surgery, 1994, 115(3): 303-309.
[13]
Dionigi G, Boni L, Rovera F, et al. Effect of perioperative blood transfusion on clinical outcomes in hepatic surgery for cancer[J]. World J Gastroenterol, 2009, 15(32): 3976-3983.
[14]
Glass NR, Miller DT, Sollinger HW, et al. A four-year experience with donor blood transfusion protocols for living-donor renal transplantation[J]. Transplantation, 1985, 39(6): 615-619.
[15]
Velasco SC. 40 years of hepato-biliary surgery[J]. Acad Peru Cir, 1965, 17(4): 385-390.
[16]
丁贺义，邰沁文，周成明,等.肝切除术应用半肝与全肝入肝血流阻断法效果的Meta分析[J].中国循证医学杂志, 2014, 14(4): 469-477.
[17]
Makuuchi M, Mori T, Gunven P, et al. Safety of hemihepatic vascular occlusion during resection of the liver[J]. Surg Gynecol Obstet, 1987, 164(2): 155-158.
[18]
严律南，袁朝新，张肇达,等.应用半肝血流阻断行肝叶切除术29例报告[J].中华外科杂志, 1994, 32(1): 35-36.
[19]
Dello SA, Reisinger KW, Dejong CH, et al. Total intermittent Pringle maneuver during liver resection can induce intestinal epithelial cell damage and endotoxemia[J]. PLoS One, 2012, 7(1): e30539.
[20]
乔治，李荣，黎沾良,等.半肝与全肝入肝血流阻断下肝切除术后肠道细菌易位影响对比研究[J].中国实用外科杂志, 2008, 28(10): 878-880.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(08): 778-784.
[2] 钟锴, 蒋铁民, 张瑞青, 吐尔干艾力·阿吉, 邵英梅, 郭强. 加速康复外科在肝囊型棘球蚴病肝切除术中的应用分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 425-429.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[5] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[6] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[7] 胡森焱, 徐冬, 方健, 谢冬冬, 王财庆. ICG荧光显影Laennec膜入路腹腔镜解剖性肝切除的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 513-516.
[8] 林巧, 周丽. RFA联合LAH术治疗原发性肝癌并门静脉癌栓的临床效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 521-524.
[9] 曾繁利, 齐秩凯, 杨贺庆. 两种经Glisson蒂鞘解剖路径肝切除术治疗原发性肝癌的肿瘤学疗效及风险比对[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 525-527.
[10] 张金华, 赵锁. 早期ICC腹腔镜肝切除术不同淋巴结清扫范围的近远期效果对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 578-581.
[11] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
[12] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[13] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[14] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
[15] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号